美国 · 经济杂志 · Quartz
Denmark's Leo Pharma is pushing its IPO plans past 2026 on market volatility

详细摘要
CEO Christophe Bourdon said Leo Pharma's owners see market conditions as unsuitable and declined to give a new timeline
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (qz.com)




